Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib and TGR-1202 in Relapsed or Refractory Lymphoma
NCT02867618Phase 2Terminated
- Sponsor
- Columbia University
- Start
- Oct 2016
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of umbralisib in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Columbia University. Started Oct 2016; status: terminated.
02
Drugs
umbralisib
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT02867618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867618.